TREATMENT OF OVARIAN CANCER WITH 4-IODO-3-NITROBENZAMIDE IN COMBINATION WITH TOPOISOMERASE INHIBITORS

摘要

Disclosed is the use of 4-iodo-3-nitrobenzamide (pictured), or a metabolite or a pharmaceutically acceptable salt thereof, and at least one topoisomerase inhibitor for the treatment of metastatic ovarian cancer. Suitable topoisomerase inhibitors include topotecan, irinotecan, lurtotecan, exatecan and camptothecin.